Chill Brands Group PLC (7HR0) AI Stock Analysis
Chill Brands Group PLC
(Frankfurt:7HR0)
No summary available
Chill Brands Group PLC (7HR0) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 888.98K
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -0.0
- Beta (1Y)
- -8.86
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Germany
- Employees
- 11
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Chill Brands Group PLC Business Overview & Revenue Model
Company Description
Chill Brands Group PLC, established in 2014, operates from its headquarters in London, United Kingdom. The company focuses on the innovation, manufacturing, and distribution of cannabidiol (CBD) consumer items and other lifestyle products across the...
Chill Brands Group PLC Peers Comparison
Overall Rating
GB:VLG71Outperform
GB:HLN63Neutral
GB:PXS49Neutral
GB:AGY42Neutral
GB:STX42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 71Outperform | GBP 80.73M | 15.60 | 7.82% | ― | ― | ― | |
| 63Neutral | GBP 28.09B | 17.61 | 9.89% | 2.29% | 1.21% | 8.33% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 49Neutral | GBP 18.77M | -80.00 | -44.68% | ― | -2.14% | 0.00% | |
| 42Neutral | GBP 253.30M | -4.04 | 409.00% | ― | 2.94% | -32.00% | |
| 42Neutral | GBP 60.69M | -7.72 | 64.57% | ― | 36.19% | 60.75% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:7HR0 | Chill Brands Group PLC | 0.01 | -0.02 | -66.67% | |
| GB:AGY | Allergy Therapeutics | 4.00 | -4.45 | -52.66% | |
| GB:PXS | Provexis plc | 0.80 | 0.22 | 36.75% | |
| GB:STX | Shield Therapeutics | 5.65 | -1.25 | -18.12% | |
| GB:VLG | Venture Life | 68.00 | 14.50 | 27.10% | |
| GB:HLN | Haleon PLC | 319.40 | -31.39 | -8.95% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.